Facebook
Twitter
LinkedIn
ForwardAnnual Urological Advocacy Summit (2023)
6th Annual Urology Advocacy Summit
Don't miss next year’s in-person AUA Summit!
February 27 – March 1, 2023
Make plans now to join the urology community in Washington, DC for the 6th Annual Urology Advocacy Summit, which is an event designed to expand, strengthen and unify the voice of urology on policy matters impacting our practices and patients. As always, we will be engaging Sections, urologic specialty organizations and patient advocacy organizations alike – and we hope you will be among them!
The dynamic conference will feature two days of in-person educational and trending policy sessions with an opportunity for attendees to earn continuing medical education credits. It also will include a day of Capitol Hill meetings. The event will leave participants feeling empowered and well-versed in advocating for policy matters that impact our practices, patients and the future of urology.
Target Audience
- young urologists
- researchers
- subspecialties
- nurses
- nurse practitioners
- physician assistants
- residents
- fellows and medical students
- patient advocates
Learning Objectives
After completing this activity, participants will be able to:
General Session – Physician Payment Reform
- Describe the significant policy changes CMS implemented in the CY 2023 PFS final rule and the policy changes outlined in the CAA of 2023.
- Describe advocacy issues that legislators need to know to develop permanent fixes to Medicare payment.
General Session – Telehealth
- Discuss specific recommendations the AUA and urologic community can use to expand telemedicine and the policy research data used to support those recommendations.
General Session – Advocating for Prostate Cancer Screenings
- Explain why certain preventative services have a mandated zero percent cost share.
- Explain how broad ranging recommendations by the USPSTF for PSA screenings impact high risk populations.
- Communicate the need to enact the PSA Screening for HIM Act.
General Session – Workforce: Present and Future
- Define why easing the workforce shortage is beneficial to the future of Urology.
- Discuss policy solutions to ease the specialty physicians’ workforce shortage.
- Communicate the need to enact the Specialty Physicians Advancing Rural Care Act.
Concurrent Session 1B – Workforce Woes: Burnout and Solutions
- Detail policy solutions to support the existing physician workforce, reduce burnout, and prevent urologists from leaving the workforce entirely.
General Session – The Role of the AMA in Physician Advocacy
- Discuss the advocacy priorities for AMA and how those align with AUA’s priorities.
- Explain the importance of the AMA House of Delegates and the AUA’s role within that policymaking body.
General Session – State Advocacy Update
- Explain the recent chaperone rules, Scope of Practice, Interstate Medical Licensure Compact, telehealth, and other hot-button issues in 2023 and how they impact urologic practice.
- Detail how to stay involved with state-level issues after the AUA Summit.
General Session – Prior Authorization or Burden Reduction Roundtable
- Discuss the various policy mechanisms through which policy makers are addressing burden reduction.
- Detail current advocacy and policy efforts to reduce administrative burdens on physicians.
General Session – Need to Know: Inflation Reduction Act of 2022 and its Impact on Urology
- Detail the real-life impacts of the IRA of 2022 on urologists and their practices.
Please visit the meeting website to view the agenda.
Planning Committee
- Robert Bass, MD, MBA
AUA Legislative Affairs Committee & AUAPAC Chair - Emily Clennon, MD, MPH
AUA Policy & Advocacy Resident Work Group Member - Maureen Cones, JD
Chief Legal and Policy Officer - Mark Edney, MD, MBA
AUA State Advocacy Committee Chair - Michael Hsieh, MD, PhD
Research Advocacy Committee Chair - Juliana Nicolini, MSW
PAC & Grassroots Advocacy Manager - Eugene Rhee, MD, MBA
AUA Public Policy Council Chair - Brad Stine
Legislative & Political Affairs Vice President - Ray Wezik, JD
Policy & Advocacy Director - Jacqueline Zarro, PhD
AUA Patient Advocacy Liaison
Faculty (CME Program)
- Eugene Rhee, MD, MBA
- Anurag Das, MD
- Mara Holton, MD
- William Reha, MD, MBA
- Lisa Finkelstein, DO
- Kara Watts, MD
- Arthur Burnett II, MD, MBA, FACS
- Adam Murphy, MD, MBA, MSCI
- Patrick Bingham, PhD
- Andrew Harris, MD
- Kate Kraft, MD, FACS, FAAP
- Jacob Thatcher, DO
- Jim Twaddell
- Daniel Frendl, MD, PhD
- Damara Kaplan, MD, PhD
- Grace Hyun, MD
- Seth Cohen, MD
- Willie Underwood, MD, MSc, MPH
- Hans Arora, MD, PhD
- Ruchika Talwar, MD
- Brian Duty, MD, MBA
- Julie Riley, MD
- Jonathan Kiechle, MD
- Beth Drzewiecki, MD
- Ali Kasraeian, MD
- Josh Langston, MD
- Erika Miller, JD
- Jeremy Haines, MA
Faculty (Non-CME Program)
- Emily Clennon, MD, MPH
- Ben Pockros, MD, MBA
- Denise Asafu-Adjei, MD, MPH
- Edward Messing, MD
- James Carville
- Logan Galansky, MD
- Emilie Johnson, MD, MPH
- Hiten Patel, MD
- Jennifer Yates, MD
- Christine Van Horn, MD
- Robert Bass, MD, MBA
- Larissa Bresler, MD
- Larry Buchshon, MD
- Jack Bergman
- Jason Jameson, MD
- Jacqueline Zarro, PhD
Note: The educational content provided in this activity is non-clinical. In accordance with the ACMCE Standards for Integrity and Independence in Accredited Continuing Education, the AUA is not required to identify, mitigate or disclose relevant financial relationships for activities that are non-clinical in nature.
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this live activity for a maximum of 5.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Mitigation of Identified Conflict of Interest: All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:
• Peer review for valid, evidence-based content by the AUA COI Review Work Group.
• Attestation that clinical recommendations are evidence-based and free of commercial bias.
• Introduction of a debate format (point-counterpoint)
• Inclusion of moderated panel discussion with unbiased moderator
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Divestiture of the relationship by faculty
• Recusal from controlling relevant aspects of planning
• Selection of alternative faculty for specific topic
Disclosure Policy Exceptions: In accordance with the ACMCE Standards for Integrity and Independence in Accredited Continuing Education, the AUA is not required to identify, mitigate or disclose relevant financial relationships for any of the activities:
• Accredited education that is non-clinical.
• Accredited education where the learner group is in control of content, such as a spontaneous case conversation among peers.
• Accredited self-directed education where the learner controls their educational goals and reports on changes that resulted.
Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
AUA PARTICIPANT INFORMATION & POLICIES
Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.
Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.
Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.
Available Credit
- 5.75 AMA PRA Category 1 Credit™
- 5.75 Non-Physician Participation